Related Experiment Video
Updated: Apr 14, 2026
05:29
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
3.3K
Targeting the Gremlin-VEGFR2 axis - a promising strategy for multiple diseases?
Robert Erdmann1, Cansu Ozden2, Jens Weidmann1
1Department of Haematology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Germany.
The Journal of Pathology
|April 16, 2015
Summary
Gremlin protein directly drives kidney inflammation through VEGFR2 signaling. This discovery offers new therapeutic targets for various diseases linked to Gremlin, including fibrosis and cancer.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Gremlin is implicated in diverse pathologies including fibrosis, angiogenesis, and cancer.
- The specific role of Gremlin in renal inflammation requires further elucidation.
Purpose of the Study:
- To investigate the direct mechanism by which Gremlin influences renal inflammation.
- To explore the involvement of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) in Gremlin-mediated renal pathology.
Main Methods:
- The study by Lavoz et al. utilized molecular and cellular assays to examine Gremlin's function.
- Specific focus on the interaction between Gremlin and VEGFR2 in kidney cells.
Main Results:
- Gremlin was shown to directly promote renal inflammation.
- This pro-inflammatory effect is mediated through the activation of VEGFR2.
Conclusions:
- Gremlin acts as a direct mediator of renal inflammation via VEGFR2.
- These findings suggest Gremlin and VEGFR2 as potential therapeutic targets for kidney diseases and other Gremlin-associated pathologies.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:57Targeted Cancer Therapies
1.8K
1.8K
01:24Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
01:16TGF - β Signaling Pathway
11.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
01:10Mechanism of Angiogenesis
7.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
02:43Mouse Models of Cancer Study
6.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K